Clinical practice guidelines for paediatric X‐linked hypophosphataemia in the era of burosumab
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Paediatrics and Child Health"
DOI: 10.1111/jpc.15976
Abstract: X‐linked hypophosphataemia (XLH), the most common inherited form of rickets, is caused by a PHEX gene mutation that leads to excessive serum levels of fibroblast growth factor 23 (FGF23). This leads to clinical manifestations such… read more here.
Keywords: era burosumab; burosumab; linked hypophosphataemia; clinical practice ... See more keywords